You are here

Find a Study

The FTD Disorders Registry plans to help support clinical trials in all of the forms of frontotemporal degeneration, including:

Behavioral variant Frontotemporal Degeneration (Dementia) (bvFTD)

Semantic variant primary progressive aphasia (svPPA)

Nonfluent/agrammatic variant PPA (naPPA)

Logopenic variant PPA (lvPPA)

Progressive supranuclear palsy (PSP)

Corticobasal degeneration (CBD)

Frontotemporal Degeneration with Amyotrophic Lateral Sclerosis (FTD-ALS)

Current Studies

Our first study partners are two clinical research networks for FTD funded by the National Institutes of Health in October, 2014.  The studies are commonly known as ARTFL and LEFFTDS.

ARTFL

The Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) consortium is a group of academic medical centers in the USA and Canada seeking volunteers to participate in a longitudinal study that will collect clinical and genetic data to learn more about the progression of FTD. If you have signed up to participate in research here on the Registry website, you may be asked to participate in online research surveys for the ARTFL project. You can find out more about ARTFL here.

LEFFTDS

The Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDS) is a network of academic medical centers in the USA and Canada seeking volunteers for a longitudinal study of individuals diagnosed with FTD caused by one of the gene mutations - MAPT, PGRN, or C9ORF72 – along with their family members who also have the mutation but may not have symptoms. The aim of the project is to better understand how gene mutations affect development of FTD and use this to support drug development. You can find out more about LEFFTDS here.

Low-Dose Lithium for Treatment of Behavioral Symptoms in FTD

The study is a randomized, placebo controlled clinical trial being run by Dr. Edward Huey at Columbia University Medical Center. It aims to test low-dose lithium carbonate as a treatment for behavioral symptoms of FTD. Participants need to have a diagnosis of FTD, PPA, or Semantic Dementia and need to be accompanied by a care partner who can provide information about the patient during interviews. The study lasts for 12 weeks, with clinic visits every two weeks. For more information, see the ClinicalTrials.gov listing.

 

More Places To Find Studies

The Association for Frontotemporal Degeneration posts a table with studies currently recruiting volunteers for the FTD disorders, AFTD-clinical trials listing.

CurePSP posts listings of studies for families affected by PSP and CBS/CBD here.

Michael J. Fox Foundation For Parkinson’s Research lists studies and can help match patients with CBD and PSP to trials using the FoxTrialFinder here.

Tissue Donation

Understanding of FTD has increased dramatically thanks to families who have been willing to donate tissue or research when a loved one passes away. This is a complex and difficult decision for any family to make. If you are interested in learning about tissue donation, there is help from AFTD here and from CurePSP here.